跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL CISPLATIN INJECTION 1 mg/ml - HSA Drug Approval Details
Approvals
/
HSA
/
DBL CISPLATIN INJECTION 1 mg/ml
Approved
THERAPEUTIC
DBL CISPLATIN INJECTION 1 mg/ml
HOSPIRA AUSTRALIA PTY LTD
🇸🇬 Health Sciences Authority
Approval Date
May 4, 1988
Approval ID
b468e148dfb9eec0
Company
HOSPIRA AUSTRALIA PTY LTD
Type
Therapeutic
Approval Details
Approval Id
b468e148dfb9eec0
Drug Name
DBL CISPLATIN INJECTION 1 mg/ml
Product Name
DBL CISPLATIN INJECTION 1 mg/ml
Approval Number
SIN00762P
Approval Date
1988-05-04
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
L01XA01
Atc Item Name
cisplatin
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Company Detail Path
/organization/pfizer-private-limited
Active Ingredients
CISPLATIN
1 mg/ml
CISPLATIN
1 mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 4, 1988
Approval ID
b468e148dfb9eec0
Type
Therapeutic
Back to HSA Approvals